Listen to Gynecologic Oncology

Gynecologic Oncology
  • 5.0 (16)
  • SCIENCE
  • UPDATED BIMONTHLY
Listen to Gynecologic Oncology

Listen to the latest news from the experts in your field.

  1. SEP 25

    LVSI in Stage 1 Endometrial Cancer

    Editor’s choice: The prognostic impact of substantial lymphovascular space invasion in women with node negative FIGO stage I uterine carcinoma Editorial: Is substantial lymphovascular space invasion in FIGO stage I endometrial carcinoma ready for primetime in deciding adjuvant treatment? Hosted by: Dr David Gaffney, MD, PhD, Associate Editor of Gynecologic Oncology Featuring: Mohamed Elshaikh, MD Beriwal Sushil MD

    18 min

  2. SEP 2

    Primary Surgery versus Radiotherapy for Inguinal Lymph Nodes in Vulvar Cancer

    Editor’s choice: Management of inguinal lymph nodes in locally advanced, surgically unresectable, squamous cell carcinoma of the vulva Editorial: Optimizing and harmonizing lymph node dissection and radiotherapy in advanced vulvar cancer Hosted by: Dr David Gaffney, MD, PhD, Associate Editor of Gynecologic Oncology Featuring:  Dr Lilian T. Gien, MD, MSc, FRCSC, University of Toronto, Canada Dr Brenna Swift, MD, FRCSC, MSc, MASc, University of Toronto, Canada Dr Scott Glaser, MD, City of Hope, USA

    32 min

  3. JUL 12

    Shifting trends and sicker patients - the future of gynecologic cancer

    Editor’s choice: Shifting trends and sicker patients: Reassessing hysterectomy performed for benign indications by gynecologic oncologists Editorial: Who you gonna call? Hosted by: David E. Cohn, MD, MBA, FACHE, Editor-in-Chief of Gynecologic Oncology Featuring: M. Dwight Chen, MD, Palo Alto Foundation Medical Group/Sutter Health Connor C. Wang, MD, Northwestern University Feinberg School of Medicine Emma Barber, MD, MS, Northwestern University Feinberg School of Medicine

    15 min

  4. JUL 8

    2023 FIGO staging for endometrial cancer: a reappraisal on the path to continuous improvement

    Reviews: 2023 changes to FIGO endometrial cancer staging: Counterpoint; 2023 FIGO staging system for endometrial cancer: The evolution of the revolution Editorial: 2023 FIGO staging for endometrial cancer, a look at both sides of the coin Hosted by: Sean Dowdy, MD, FACS, FACOG, Associate Editor of Gynecologic Oncology  Featuring:  Dr. Alexander Olawaiye, MD, University of Pittsburgh School of Medicine, USA Dr. David Gaffney, MD-PhD, University of Utah, USA Dr. Mario Leitao, Jr., MD, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, USA

    37 min

  5. APR 15

    Editor's Choice: SENTIREC-endo study: Is the juice worth the squeeze?

    Editor’s Choice Paper: Identifying safe diagnostic algorithms for sentinel lymph node mapping in high-risk endometrial cancer: The SENTIREC-endo study Editorial: Sentinel lymph node biopsy in high-risk endometrial cancer: The dénouement Hosted by: Gregg Nelson, MD, Social Media Editor of Gynecologic Oncology Featuring: Sarah M. Bjørnholt, MD, Aarhus University Hospital, Denmark Sean Dowdy, MD, Mayo Clinic, USA

    13 min

  6. APR 4

    Editor's Choice: Caring for the Caregiver

    Editor’s Choice Paper:  Experiences of patients with peritoneal carcinomatosis-related complex care needs and their caregivers Editorial: The importance of family-focused care in the setting of advanced gynecological cancers Hosted by: Sean Dowdy, MD, Associate Editor of Gynecologic Oncology Featuring: Rachel A. Pozzar, PhD, RN, Dana Farber Cancer Institute and Harvard Medical School Allison J. Applebaum, PhD, Caregivers Clinic, Memorial Sloan Kettering Cancer Center

    20 min

  7. MAR 1

    Editor’s Choice: Lunchbox Trial

    Editor’s Choice Paper:  Lunchbox trial: A randomized phase III trial of cisplatin and irradiation followed by carboplatin and paclitaxel versus sandwich therapy of carboplatin and paclitaxel followed by irradiation then carboplatin and paclitaxel for advanced endometrial carcinoma Editorial: What's in your “lunchbox”? Sandwich versus sequential chemotherapy and irradiation for advanced endometrial cancer Hosted by: Ursula Matulonis, MD, Associate Editor of Gynecologic Oncology Featuring: Joyce Barlin, MD, Women’s Cancer Care Associates & Albany Medical College Gretchen Glaser, MD, Mayo Clinic  John Weroha, MD, Mayo Clinic

    10 min

  8. 11/17/2023

    October 2023 Editor’s Choice: OS updates for Imagyn50

    Editor’s Choice Paper:  Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer Hosted by: Ursula Matulonis, MD, Associate Editor of Gynecologic Oncology Featuring: Kathleen N. Moore, MD, GOG-F and Stephenson Cancer Center at the University of Oklahoma Health Sciences Center

    14 min
See All (44)

Ratings & Reviews

5
out of 5
16 Ratings

About

Listen to the latest news from the experts in your field.

Information

You Might Also Like

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes, and get the latest updates.
Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada